Twitter Facebook LinkedIn

News & Events

February 8, 2022 | SOAR 201910

SOAR 201910 Programme
Conducted by GSK
Active: 2015-2017

Studies: 18

Regions: Argentina, Costa Rica, Chile, Pakistan, Turkey, Saudi Arabia, Morocco, Tunisia, Lebanon, Kuwait, Ghana, Kenya, Ethiopia, Ukraine, Vietnam, Cambodia, Philippines, Singapore

Primary objective
Data generation for antibiotic resistance of the main community-acquired respiratory tract infection pathogens such as S.pneumoniae and H.influenzae. This is an ongoing study and will be finalized in 2019.